Dengue virus infection-enhancing and neutralizing antibody balance in children of the Philippines and Indonesia

Microbes and Infection

Volumn 14, Issue 13, 2012, Pages 1152-1159

  Yamanaka, Atsushi ^a,b   Tabuchi, Yuko ^c   Mulyatno, Kris C ^a   Susilowati, Helen ^a   Hendrianto, Eryk ^a   Soegijanto, Soegeng ^a   Konishi, Eiji ^b,c,d  

^a AIRLANGGA UNIVERSITY   (Indonesia)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY   (Japan)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Antibody dependent enhancement; Dengue; Epidemiology; Indonesia; Neutralization tests; Philippines

Indexed keywords

COMPLEMENT; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DIAGNOSTIC TEST ACCURACY STUDY; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; INDONESIA; INFANT; MAJOR CLINICAL STUDY; MALE; PHILIPPINES; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEROLOGY; SERUM; VIRUS STRAIN; VIRUS TYPING;

ANTIBODIES, BLOCKING; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; CHILD; CHILD, PRESCHOOL; COMPLEMENT SYSTEM PROTEINS; DENGUE; DENGUE VIRUS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENDEMIC DISEASES; HUMANS; INDONESIA; INFANT; NEUTRALIZATION TESTS; PHILIPPINES; RECEPTORS, COMPLEMENT; SEVERE DENGUE;

DENGUE VIRUS;

EID: 84868127887     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.07.013     Document Type: Article

References (31)

1. Wilder-Smith A., Ooi E.E., Vasudevan S.G., Gubler D.J. Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr. Infect. Dis. Rep. 2010, 12:157-164.
2. Halstead S.B. Dengue. Lancet 2007, 370:1644-1652.
3. Green S., Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr. Opin. Infect. Dis. 2006, 19:429-436.
4. Halstead S.B., O'Rourke E.J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 1977, 265:739-741.
5. Kliks S.C., Nisalak A., Brandt W.E., Wahl L., Burke D.S. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 1989, 40:444-451.
6. Kurane I., Mady B.J., Ennis F.A. Antibody-dependent enhancement of dengue virus infection. Rev. Med. Virol. 1991, 1:211-221.
7. Hombach J., Cardosa M.L., Sabchareon A., Vaughn D.W., Barrett A.D. Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005. Vaccine 2007, 25:4130-4139.
8. Pierson T.C., Diamond M.S. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev. Mol. Med. 2008, 10:e12.
9. Rodrigo W.W., Jin X., Blackley S.D., Rose R.C., Schlesinger J.J. Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32). J. Virol. 2006, 80:10128-10138.
10. Moi M.L., Lim C.K., Kotaki A., Takasaki T., Kurane I. Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA. J. Virol. Methods 2010, 163:205-209.
11. Guy B., Chanthavanich P., Gimenez S., Sirivichayakul C., Sabchareon A., Begue S., Yoksan S., Luxemburger C., Lang J. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine. Vaccine 2004, 22:3563-3574.
12. Laoprasopwattana K., Libraty D.H., Endy T.P., Nisalak A., Chunsuttiwat S., Vaughn D.W., Reed G., Ennis F.A., Rothman A.L., Green S. Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection. J. Infect. Dis. 2005, 192:510-519.
13. Martin N.C., Pardo J., Simmons M., Tjaden J.A., Widjaja S., Marovich M.A., Sun W., Porter K.R., Burgess T.H. An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies. J. Virol. Methods 2006, 134:74-85.
14. Kraus A.A., Messer W., Haymore L.B., de Silva A.M. Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization. J. Clin. Microbiol. 2007, 45:3777-3780.
15. Fagbami A., Halstead S.B., Marchette N., Larsen K. Heterologous flavivirus infection-enhancing antibodies in sera of Nigerians. Am. J. Trop. Med. Hyg. 1988, 38:205-207.
16. Chau T.N., Quyen N.T., Thuy T.T., Tuan N.M., Hoang D.M., Dung N.T., Lien le B., Quy N.T., Hieu N.T., Hieu L.T., Hien T.T., Hung N.T., Farrar J., Simmons C.P. Dengue in Vietnamese infants-results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. J. Infect. Dis. 2008, 198:516-524.
17. Konishi E., Tabuchi Y., Yamanaka A. A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells. J. Virol. Methods 2010, 163:360-367.
18. Mehlhop E., Ansarah-Sobrinho C., Johnson S., Engle M., Fremon D.H., Pierson T.C., Diamond M.S. Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Cell Host Microbe 2007, 2:417-426.
19. Yamanaka A., Kosugi S., Konishi E. Infection-enhancing and -neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels. J. Virol. 2008, 82:927-937.
20. Konishi E., Miyagawa Y. Balance of infection-enhancing and neutralizing antibodies induced by a dengue tetravalent DNA vaccine in a mouse model. Microbes Infect. 2011, 13:1091-1098.
21. Kawashima T., Khin-Sane-Win, Kawabat M., Barzaga N., Matsuda H., Konishi E. Prevalence of antibodies to Toxoplasma gondii among urban and rural residents in the Philippines. Southeast Asian J. Trop. Med. Public Health 2000, 31:742-746.
22. Konishi E., Houki T., Harano K., Retno S.M., Djoko M., Soetrisno A., Yoes P.D. High prevalence of antibody to Toxoplasma gondii among humans in Surabaya, Indonesia. Jpn. J. Infect. Dis. 2000, 53:238-241.
23. Konishi E., Kosugi S., Imoto J. Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice. Vaccine 2006, 24:2200-2207.
24. Konishi E., Fujii A. Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine. Vaccine 2002, 20:1058-1067.
25. Halstead S.B. Neutralization and antibody-dependent enhancement of dengue viruses. Adv. Virus. Res. 2003, 60:421-467.
26. Bokisch V.A., Top F.H., Russell P.K., Dixon F.J., Muller-Eberhard H.J. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N. Engl. J. Med. 1973, 289:996-1000.
27. Nishioka K. Serum complement level in dengue hemorrhagic fever. Allerg. Immunol. 1974-1975, 20-21:385-392.
28. Avirutnan P., Punyadee N., Noisakran S., Komoltri C., Thiemmeca S., Auethavornanan K., Jairungsri A., Kanlaya R., Tangthawornchaikul N., Puttikhunt C., Pattanakitsakul S.N., Yenchitsomanus P.T., Mongkolsapaya J., Kasinrerk W., Sittisombut N., Husmann M., Blettner M., Vasanawathana S., Bhakdi S., Malasit P. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J. Infect. Dis. 2006, 193:1078-1088.
29. Nascimento E.J., Silva A.M., Cordeiro M.T., Brito C.A., Gil L.H., Braga-Neto U., Marques E.T. Alternative complement pathway deregulation is correlated with dengue severity. PLoS One 2009, 4:e6782.
30. Capeding M.R., Paladin F.J., Miranda E.G., Navarro X.R. Dengue surveillance in Metro Manila. Southeast Asian J. Trop. Med. Public Health 1997, 28:530-534.
31. Salda L.T., Parquet M.D., Matias R.R., Natividad F.F., Kobayash N., Morita K. Molecular epidemiology of dengue 2 viruses in the Philippines: genotype shift and local evolution. Am. J. Trop. Med. Hyg. 2005, 73:796-802.